By embracing cloud-enabled solutions, governments can accelerate innovation, improve collaboration and optimise their ...
Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...
In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback